<?xml version="1.0" encoding="UTF-8"?>
<p id="Par2">Antiviral compounds effective in infections caused by tropical and vector-borne viruses were a neglected topic of international antivirals research until very recently. A number of compounds are now in clinical trials, and very few have received regulatory approval, or have made it to the market.</p>
